Sara P. Ginzberg

Sara P. Ginzberg

Auto-generated profile, based on publicly available information

Sara P. Ginzberg

Department of Surgery, University of Pennsylvania Health System, Philadelphia, PA

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 June 2024 in JAMA Network Open
Verified
Journal Article
Closed access
PDF file
SGSara P. Ginzberg
Sara P. Ginzberg
JGJulia A. Gasior
Julia A. Gasior
JPJesse E. Passman
Jesse E. Passman
JSJacob Stein
Jacob Stein
SKShimrit Keddem
Shimrit Keddem
HWHeather Wachtel
Heather Wachtel
Medical errors are estimated to be the third most common cause of death in the US, with more than 250 000 deaths attributable to medical errors annually.1,2 Nearly all physicians report having made at least 1 error during their career.3 Despite the frequency of medical errors, it can be very disturbing for physicians to realize that they have unintentionally harmed a patient.4

20 November 2023 in Surgery
Verified
Journal Article
Closed access
CFCaitlin B. Finn
Caitlin B. Finn
JSJames E. Sharpe
James E. Sharpe
LKLauren N. Krumeich
Lauren N. Krumeich
SGSara P. Ginzberg
Sara P. Ginzberg
JBJacqueline M. Soegaard Ballester
Jacqueline M. Soegaard Ballester
RKRachel R. Kelz
Rachel R. Kelz

7 February 2023 in Annals of Surgical Oncology
Verified
Journal Article
Closed access
PDF file
SGSara P. Ginzberg
Sara P. Ginzberg
JBJacqueline M. Soegaard Ballester
Jacqueline M. Soegaard Ballester
CWChristopher J. Wirtalla
Christopher J. Wirtalla
KMKnashawn H. Morales
Knashawn H. Morales
DPDaniel A. Pryma
Daniel A. Pryma
HWHeather Wachtel
Heather Wachtel

25 February 2023 in Annals of Surgical Oncology
Verified
Journal Article
Closed access
PDF file
SGSara P. Ginzberg
Sara P. Ginzberg
JBJacqueline M. Soegaard Ballester
Jacqueline M. Soegaard Ballester
CWChristopher J. Wirtalla
Christopher J. Wirtalla
KMKnashawn H. Morales
Knashawn H. Morales
DPDaniel A. Pryma
Daniel A. Pryma
HWHeather Wachtel
Heather Wachtel

1 August 2024 in Thyroid®
Verified
Journal Article
Closed access
SGSara P. Ginzberg
Sara P. Ginzberg
JSJames Sharpe
James Sharpe
JPJesse E. Passman
Jesse E. Passman
WAWajid Amjad
Wajid Amjad
CWChristopher J. Wirtalla
Christopher J. Wirtalla
HWHeather Wachtel
Heather Wachtel
Large tumor size is associated with poorer outcomes in well-differentiated thyroid cancer (WDTC), yet it remains unclear whether size >4 cm alone confers increased risk, independent of other markers of aggressive disease. The goal of this study was to assess the relationship between tumor size, other high-risk histopathologic features, and survival in WDTC, and to evaluate the significance of 4 cm as a cutoff for management decisions. Patients with WDTC were identified from the National Cancer Database (2010-2015) and categorized by tumor size [i.e., small (≤4 cm) or large (>4 cm)] and presence of high-risk histopathologic features (e.g., extrathyroidal extension). First, propensity score matching was used to identify patients who were similar across all other observed characteristics except for small vs. large tumor size, and a multivariable Cox proportional hazards model was used to estimate the relationship between tumor size and survival. Second, we assessed whether the presence of high-risk features demonstrate conditional effects on survival based on the presence of tumor size >4 cm using an interaction term. Finally, additional models assessed the relationship between incremental 1 cm increases in tumor size and survival. Analyses were repeated using a validation cohort from the Surveillance, Epidemiology, and End Results Program (2008-2013). Of 193,133 patients in the primary cohort, 7.9% had tumors >4 cm, and 30% had at least one high-risk feature. After matching, tumor size >4 cm was independently associated with worse survival (HR 1.63, p4 cm and one or more other high-risk features together yielded worse survival than either size >4 cm alone (MMD: 0.70, p<0.001) or other high-risk features alone (MMD: 0.49, p<0.001). When assessed in 1 cm increments, the largest increases in hazard of death occurred at 2 cm and 5 cm, not 4 cm. Results from the validation cohort were largely consistent with our primary findings. Concomitant high-risk features confer worse survival than large tumor size alone, and a 4 cm cutoff is not associated with the greatest increase in risk. These findings support a more nuanced approach to tumor size in the management of WDTC.

2 May 2023 in Journal of Surgical Research
Verified
Journal Article
Closed access
SGSara P. Ginzberg
Sara P. Ginzberg
JBJacqueline M. Soegaard Ballester
Jacqueline M. Soegaard Ballester
CWChris J. Wirtalla
Chris J. Wirtalla
DPDaniel A. Pryma
Daniel A. Pryma
SMSusan J. Mandel
Susan J. Mandel
HWHeather Wachtel
Heather Wachtel